Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

$24.99

Analysis of Reportable Segments

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Segment Profit Margin

Thermo Fisher Scientific Inc., profit margin by reportable segment

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Segment profitability ratio Reportable segment The company
Segment profit margin Life Sciences Solutions Life Sciences Solutions segment profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023.
Analytical Instruments Analytical Instruments segment profit margin ratio improved from 2021 to 2022 and from 2022 to 2023.
Specialty Diagnostics Specialty Diagnostics segment profit margin ratio deteriorated from 2021 to 2022 but then improved from 2022 to 2023 exceeding 2021 level.
Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment profit margin ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Profit Margin: Life Sciences Solutions

Thermo Fisher Scientific Inc.; Life Sciences Solutions; segment profit margin calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Revenues
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment profit margin = 100 × Segment income ÷ Revenues
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Life Sciences Solutions Life Sciences Solutions segment profit margin ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment Profit Margin: Analytical Instruments

Thermo Fisher Scientific Inc.; Analytical Instruments; segment profit margin calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Revenues
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment profit margin = 100 × Segment income ÷ Revenues
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Analytical Instruments Analytical Instruments segment profit margin ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Profit Margin: Specialty Diagnostics

Thermo Fisher Scientific Inc.; Specialty Diagnostics; segment profit margin calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Revenues
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment profit margin = 100 × Segment income ÷ Revenues
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Specialty Diagnostics Specialty Diagnostics segment profit margin ratio deteriorated from 2021 to 2022 but then improved from 2022 to 2023 exceeding 2021 level.

Segment Profit Margin: Laboratory Products and Biopharma Services

Thermo Fisher Scientific Inc.; Laboratory Products and Biopharma Services; segment profit margin calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Revenues
Segment Profitability Ratio
Segment profit margin1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment profit margin = 100 × Segment income ÷ Revenues
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment profit margin Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment profit margin ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Return on Assets (Segment ROA)

Thermo Fisher Scientific Inc., ROA by reportable segment

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Segment profitability ratio Reportable segment The company
Segment ROA Life Sciences Solutions Life Sciences Solutions segment ROA deteriorated from 2021 to 2022 and from 2022 to 2023.
Analytical Instruments Analytical Instruments segment ROA improved from 2021 to 2022 and from 2022 to 2023.
Specialty Diagnostics Specialty Diagnostics segment ROA deteriorated from 2021 to 2022 and from 2022 to 2023.
Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment ROA improved from 2021 to 2022 and from 2022 to 2023.

Segment ROA: Life Sciences Solutions

Thermo Fisher Scientific Inc.; Life Sciences Solutions; segment ROA calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment ROA = 100 × Segment income ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Life Sciences Solutions Life Sciences Solutions segment ROA deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment ROA: Analytical Instruments

Thermo Fisher Scientific Inc.; Analytical Instruments; segment ROA calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment ROA = 100 × Segment income ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Analytical Instruments Analytical Instruments segment ROA improved from 2021 to 2022 and from 2022 to 2023.

Segment ROA: Specialty Diagnostics

Thermo Fisher Scientific Inc.; Specialty Diagnostics; segment ROA calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment ROA = 100 × Segment income ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Specialty Diagnostics Specialty Diagnostics segment ROA deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment ROA: Laboratory Products and Biopharma Services

Thermo Fisher Scientific Inc.; Laboratory Products and Biopharma Services; segment ROA calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Segment income
Total assets
Segment Profitability Ratio
Segment ROA1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment ROA = 100 × Segment income ÷ Total assets
= 100 × ÷ =

Segment profitability ratio Reportable segment The company
Segment ROA Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment ROA improved from 2021 to 2022 and from 2022 to 2023.

Segment Asset Turnover

Thermo Fisher Scientific Inc., asset turnover by reportable segment

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Segment activity ratio Reportable segment The company
Segment asset turnover Life Sciences Solutions Life Sciences Solutions segment asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.
Analytical Instruments Analytical Instruments segment asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023.
Specialty Diagnostics Specialty Diagnostics segment asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.
Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Asset Turnover: Life Sciences Solutions

Thermo Fisher Scientific Inc.; Life Sciences Solutions; segment asset turnover calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Revenues
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment asset turnover = Revenues ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Life Sciences Solutions Life Sciences Solutions segment asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment Asset Turnover: Analytical Instruments

Thermo Fisher Scientific Inc.; Analytical Instruments; segment asset turnover calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Revenues
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment asset turnover = Revenues ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Analytical Instruments Analytical Instruments segment asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Asset Turnover: Specialty Diagnostics

Thermo Fisher Scientific Inc.; Specialty Diagnostics; segment asset turnover calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Revenues
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment asset turnover = Revenues ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Specialty Diagnostics Specialty Diagnostics segment asset turnover ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment Asset Turnover: Laboratory Products and Biopharma Services

Thermo Fisher Scientific Inc.; Laboratory Products and Biopharma Services; segment asset turnover calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Revenues
Total assets
Segment Activity Ratio
Segment asset turnover1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment asset turnover = Revenues ÷ Total assets
= ÷ =

Segment activity ratio Reportable segment The company
Segment asset turnover Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment asset turnover ratio improved from 2021 to 2022 and from 2022 to 2023.

Segment Capital Expenditures to Depreciation

Thermo Fisher Scientific Inc., capital expenditures to depreciation by reportable segment

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Life Sciences Solutions Life Sciences Solutions segment capital expenditures to depreciation ratio deteriorated from 2021 to 2022 and from 2022 to 2023.
Analytical Instruments Analytical Instruments segment capital expenditures to depreciation ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023.
Specialty Diagnostics Specialty Diagnostics segment capital expenditures to depreciation ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023.
Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment capital expenditures to depreciation ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment Capital Expenditures to Depreciation: Life Sciences Solutions

Thermo Fisher Scientific Inc.; Life Sciences Solutions; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Capital expenditures
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Life Sciences Solutions Life Sciences Solutions segment capital expenditures to depreciation ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Segment Capital Expenditures to Depreciation: Analytical Instruments

Thermo Fisher Scientific Inc.; Analytical Instruments; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Capital expenditures
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Analytical Instruments Analytical Instruments segment capital expenditures to depreciation ratio improved from 2021 to 2022 but then deteriorated significantly from 2022 to 2023.

Segment Capital Expenditures to Depreciation: Specialty Diagnostics

Thermo Fisher Scientific Inc.; Specialty Diagnostics; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Capital expenditures
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Specialty Diagnostics Specialty Diagnostics segment capital expenditures to depreciation ratio improved from 2021 to 2022 but then slightly deteriorated from 2022 to 2023.

Segment Capital Expenditures to Depreciation: Laboratory Products and Biopharma Services

Thermo Fisher Scientific Inc.; Laboratory Products and Biopharma Services; segment capital expenditures to depreciation calculation

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Selected Financial Data (US$ in millions)
Capital expenditures
Depreciation
Segment Financial Ratio
Segment capital expenditures to depreciation1

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

1 2023 Calculation
Segment capital expenditures to depreciation = Capital expenditures ÷ Depreciation
= ÷ =

Segment financial ratio Reportable segment The company
Segment capital expenditures to depreciation Laboratory Products and Biopharma Services Laboratory Products and Biopharma Services segment capital expenditures to depreciation ratio deteriorated from 2021 to 2022 and from 2022 to 2023.

Revenues

Thermo Fisher Scientific Inc., revenues by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services
Eliminations
Consolidated

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Segment income

Thermo Fisher Scientific Inc., segment income by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services
Consolidated

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Depreciation

Thermo Fisher Scientific Inc., depreciation by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services
Consolidated

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Total assets

Thermo Fisher Scientific Inc., total assets by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services
Corporate/other
Consolidated

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).


Capital expenditures

Thermo Fisher Scientific Inc., capital expenditures by reportable segment

US$ in millions

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Life Sciences Solutions
Analytical Instruments
Specialty Diagnostics
Laboratory Products and Biopharma Services
Corporate/other
Consolidated

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).